Camille I. Farhat

Biography

  Camille Farhat joined RTI Surgical as president and chief executive officer in March 2017. His experience is built from extensive work across multiple companies in 10 countries and nine industries, including experience in the healthcare industry globally spanning pharmaceuticals, implantable devices, capital equipment, consumables and services. Prior to joining RTI, Farhat was president and CEO of American Medical Systems (AMS). Prior to AMS, he advanced several business segments for Baxter International, serving as global general manager of Baxter Pharmaceuticals & Technologies and global general manager of Global Infusion Systems. Prior to Baxter, he was vice president of business development at Medtronic, and previously global general manager of the company’s gastroenterology and urology divisions. Earlier in his career, Farhat gained executive and leadership experience during his 13 years at General Electric. He earned a Master of Business Administration from Harvard University, a degree in European Union Studies from Institut National d’Etudes Politiques de Paris and graduated summa cum laude from Northeastern University with a bachelor’s degree in international finance and accounting. In his role, Farhat oversees all aspects of the company and its affiliates. He provides an insider’s perspective in board discussions about the business and strategic direction of the company.

Research Interest

 management, marketing